4-Hydroxynonenal induces an increase in expression of receptor for activating C Kinase 1 (RACK1) in Chinese hamster V79-4 lung cells
Li, Dan and Ellis, Elizabeth M (2014) 4-Hydroxynonenal induces an increase in expression of receptor for activating C Kinase 1 (RACK1) in Chinese hamster V79-4 lung cells. Chemico-Biological Interactions, 213. pp. 13-20. ISSN 0009-2797 (https://doi.org/10.1016/j.cbi.2014.01.020)
Full text not available in this repository.Request a copyAbstract
4-Hydroxy-trans-2-nonenal (HNE) is a cytotoxic α,β-unsaturated aldehyde implicated in the pathology of several diseases that have an oxidative stress mechanism, including atherosclerosis, diabetes, alcohol-induced liver disease, and neurodegenerative disorders. As the most toxic aldehydic product of lipid peroxidation, HNE is known to exert a range of biological effects in a concentration-dependent manner. In this study, the effect of HNE on the levels of proteins in V79-4 Chinese hamster lung cells was investigated using two-dimensional electrophoresis and mass spectrometry. The results revealed that the expression of 23 proteins was increased by at least 2-fold and the expression of 19 proteins was decreased by at least 2-fold after exposure to 10μM HNE for 24h. Decreased proteins included the metabolic enzyme phosphoglycerate kinase 1 (PGK1), levels of which were decreased by 47%. Levels of the apoptotic indicator Lamin C were decreased by 33%. In contrast, levels of the scaffolding protein Receptor for Activating C Kinase 1 (RACK1) were increased by 2-fold after treatment with 10μM HNE for 24h, and this was confirmed using quantitative PCR of reverse-transcribed mRNA and Western blots. The role of RACK1 in mediating the induction of apoptosis in response to 10μM HNE was confirmed using RACK1-specific siRNA. The results from this study provide new information on the mechanism of adaptive stress response to HNE and also identify potential new biomarkers of exposure to HNE.
-
-
Item type: Article ID code: 47294 Dates: DateEvent25 April 2014Published10 February 2014Published OnlineSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 02 Apr 2014 11:30 Last modified: 11 Nov 2024 10:38 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/47294